The prescription device, dubbed EaseVRx, comprises a VR headset with a breathing amplifier attachment that guides a patient through deep breathing exercises. The program uses cognitive behavioral therapy methods — including deep relaxation, attention-shifting and healthy movement — to help the patient address physiological symptoms of pain to support overall relief.
The EaseVRx eight-week at-home treatment program consists of 56 VR sessions, which are between two minutes and 16 minutes apiece. The FDA evaluated the treatment based on a 179 person randomized control trial that showed patients who used the VR system reported greater pain reduction both immediately after treatment and at a one-month follow up, according to the FDA’s news release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
